Choreo LLC’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$5.69M Buy
79,251
+5,894
+8% +$454K 0.07% 199
2025
Q4
$5.86M Buy
73,357
+9,767
+15% +$770K 0.07% 184
2025
Q3
$4.79M Buy
63,590
+1,439
+2% +$98.6K 0.06% 207
2025
Q2
$4.29M Buy
62,151
+3,020
+5% +$198K 0.06% 219
2025
Q1
$4.01M Sell
59,131
-5,919
-9% -$354K 0.06% 212
2024
Q4
$2.88M Sell
65,050
-4,886
-7% -$274K 0.04% 269
2024
Q3
$4.3M Buy
69,936
+6,106
+10% +$356K 0.06% 208
2024
Q2
$3.71M Buy
63,830
+47,655
+295% +$2.98M 0.06% 201
2024
Q1
$1.29M Buy
16,175
+2,274
+16% +$174K 0.03% 237
2023
Q4
$1.1M Buy
13,901
+6,792
+96% +$483K 0.03% 247
2023
Q3
$496K Buy
7,109
+1,542
+28% +$109K 0.02% 289
2023
Q2
$385K Sell
5,567
-960
-15% -$68.3K 0.01% 338
2023
Q1
$485K Buy
6,527
+1,719
+36% +$144K 0.02% 301
2022
Q4
$447K Buy
4,808
+585
+14% +$56.4K 0.02% 154
2022
Q3
$403K Sell
4,223
-24
-0.6% -$2.38K 0.02% 140
2022
Q2
$394K Sell
4,247
-403
-9% -$39.3K 0.02% 145
2022
Q1
$471K Buy
4,650
+505
+12% +$53.1K 0.02% 145
2021
Q4
$428K Sell
4,145
-231
-5% -$21.3K 0.02% 153
2021
Q3
$371K Sell
4,376
-61
-1% -$5.11K 0.02% 157
2021
Q2
$370K Buy
4,437
+106
+2% +$8.68K 0.02% 156
2021
Q1
$326K Buy
4,331
+1,000
+30% +$72.8K 0.02% 150
2020
Q4
$228K Sell
3,331
-225
-6% -$14.6K 0.02% 180
2020
Q3
$208K Hold
3,556
0.02% 170
2020
Q2
$231K Sell
3,556
-457
-11% -$28.8K 0.02% 165
2020
Q1
$238K Sell
4,013
-1,970
-33% -$132K 0.03% 154
2019
Q4
$444K Sell
5,983
-1,129
-16% -$79.3K 0.04% 126
2019
Q3
$449K Sell
7,112
-917
-11% -$54.3K 0.05% 120
2019
Q2
$438K Sell
8,029
-860
-10% -$46.3K 0.05% 127
2019
Q1
$479K Buy
8,889
+1,777
+25% +$110K 0.06% 116
2018
Q4
$466K Buy
7,112
+1,141
+19% +$85.2K 0.07% 110
2018
Q3
$470K Buy
5,971
+1,017
+21% +$72.7K 0.06% 128
2018
Q2
$319K Buy
+4,954
New +$326K 0.04% 177
2018
Q1
Sell
-7,398
Closed -$536K 280
2017
Q4
$536K Sell
7,398
-1,876
-20% -$136K 0.06% 149
2017
Q3
$754K Buy
9,274
+854
+10% +$67.6K 0.1% 106
2017
Q2
$678K Buy
8,420
+1,135
+16% +$89.6K 0.1% 115
2017
Q1
$572K Sell
7,285
-1,059
-13% -$84.5K 0.08% 126
2016
Q4
$658K Buy
8,344
+928
+13% +$75.1K 0.1% 110
2016
Q3
$660K Buy
7,416
+2,066
+39% +$195K 0.12% 97
2016
Q2
$512K Buy
5,350
+512
+11% +$51K 0.1% 105
2016
Q1
$502K Buy
4,838
+391
+9% +$38K 0.1% 99
2015
Q4
$373K Buy
4,447
+871
+24% +$85.3K 0.09% 99
2015
Q3
$345K Buy
3,576
+1,316
+58% +$138K 0.09% 101
2015
Q2
$237K Buy
2,260
+51
+2% +$5.21K 0.06% 130
2015
Q1
$228K Sell
2,209
-558
-20% -$56.5K 0.06% 134
2014
Q4
$266K Sell
2,767
-87
-3% -$7.67K 0.07% 121
2014
Q3
$227K Buy
2,854
+119
+4% +$9.38K 0.07% 131
2014
Q2
$206K Sell
2,735
-2,749
-50% -$208K 0.06% 138
2014
Q1
$411K Buy
+5,484
New +$387K 0.12% 83

Other funds holding CVS

Choreo LLC's CVS Position: Q1 2026 in Review

Choreo LLC increased its CVS Health (CVS) stake by 8% in Q1 2026, buying an estimated $454K and bringing the position to 79,251 shares worth $5.69M. The position accounts for 0.07% of the portfolio, ranked #199.

Choreo LLC first reported a position in CVS in Q1 2014 and has held it in 48 quarters since. The position peaked at $5.86M in Q4 2025. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Choreo LLC held 79,251 shares of CVS Health worth $5.69M as of Q1 2026.
  • Choreo LLC bought 5,894 CVS Health shares in Q1 2026, an estimated $454K.
  • CVS Health made up 0.07% of Choreo LLC's portfolio in Q1 2026, its #199 holding.
  • Choreo LLC first reported a position in CVS Health in Q1 2014 and has held it in 48 quarters since.
  • Choreo LLC's CVS Health position peaked at $5.86M in Q4 2025.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Choreo LLC's 13F filing for Q1 2026, filed 13 May 2026.